Abstract:Hypoxia is a condition commonly observed in the core of solid tumors. The hypoxia-inducible factors (HIF) act as hypoxia sensors that orchestrate a coordinated response increasing the pro-survival and pro-invasive phenotype of cancer cells, and determine a broad metabolic rewiring. These events favor tumor progression and chemoresistance. The increase in glucose and amino acid uptake, glycolytic flux, and lactate production; the alterations in glutamine metabolism, tricarboxylic acid cycle, and oxidative phosphorylation; the high levels of mitochondrial reactive oxygen species; the modulation of both fatty acid synthesis and oxidation are hallmarks of the metabolic rewiring induced by hypoxia. This review discusses how metabolic-dependent factors (e.g., increased acidification of tumor microenvironment coupled with intracellular alkalinization, and reduced mitochondrial metabolism), and metabolic-independent factors (e.g., increased expression of drug efflux transporters, stemness maintenance, and epithelial-mesenchymal transition) cooperate in determining chemoresistance in hypoxia. Specific metabolic modifiers, however, can reverse the metabolic phenotype of hypoxic tumor areas that are more chemoresistant into the phenotype typical of chemosensitive cells. We propose these metabolic modifiers, able to reverse the hypoxia-induced metabolic rewiring, as potential chemosensitizer agents against hypoxic and refractory tumor cells.

Central role of hypoxia-inducible factor-1α in metabolic reprogramming of cancer cells: A review

Hypoxia and Cancer Cell Metabolism

Therapeutic Targeting Hypoxia-Inducible Factor (HIF-1) in Cancer: Cutting Gordian Knot of Cancer Cell Metabolism

Cancer Cell Metabolism in Hypoxia: Role of HIF-1 as Key Regulator and Therapeutic Target

HIF-1α pathway: role, regulation and intervention for cancer therapy

Small Molecules Targeting HIF-1α Pathway for Cancer Therapy in Recent Years

HIF-1-Dependent Reprogramming of Glucose Metabolic Pathway of Cancer Cells and Its Therapeutic Significance

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

HIF-1α signaling: Essential roles in tumorigenesis and implications in targeted therapies

Targeting Hypoxia-Inducible Factor-1-Mediated Metastasis for Cancer Therapy

Metabolomic Investigations into Hypoxia-Mediated Metabolic Reprogramming of Pancreatic Cancer Cells

Cancer Therapy by Targeting Hypoxia-Inducible Factor-1.

Hypoxia and Metabolism in Metastasis

Hypoxia Dictates Metabolic Rewiring of Tumors: Implications for Chemoresistance

Hypoxia Inducible Factor-1 alpha: A New Anticancer Drug Target

Autonomous Glucose Metabolic Reprogramming of Tumour Cells under Hypoxia: Opportunities for Targeted Therapy

Role of hypoxia inducible factor-1 in cancer stem cells

Analysis of Hypoxia-Induced Metabolic Reprogramming.

Role of hypoxia in the hallmarks of human cancer.

The role of hypoxia-inducible factors in metabolic diseases

Targeting Hypoxia-Inducible Factor-1 (HIF-1) in Cancer: Emerging Therapeutic Strategies and Pathway Regulation